Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global COVID-19 pandemic. Rapidly-spreading SARS-CoV-2 variants may jeopardize newly-introduced antibody and vaccine countermeasures. Here, using monoclonal antibodies (mAbs), animal immune sera, human convalescent sera, and...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Nat Med
Huvudupphovsmän: Chen, Rita E., Zhang, Xianwen, Case, James Brett, Winkler, Emma S., Liu, Yang, VanBlargan, Laura A., Liu, Jianying, Errico, John M., Xie, Xuping, Suryadevara, Naveenchandra, Gilchuk, Pavlo, Zost, Seth J., Tahan, Stephen, Droit, Lindsay, Turner, Jackson S., Kim, Wooseob, Schmitz, Aaron J., Thapa, Mahima, Wang, David, Boon, Adrianus C.M., Presti, Rachel M., O’Halloran, Jane A., Kim, Alfred H.J., Deepak, Parakkal, Pinto, Dora, Fremont, Daved H., Crowe, James E., Corti, Davide, Virgin, Herbert W., Ellebedy, Ali H., Shi, Pei-Yong, Diamond, Michael S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2021
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8058618/
https://ncbi.nlm.nih.gov/pubmed/33664494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41591-021-01294-w
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk